financetom
Business
financetom
/
Business
/
Tata Power hopeful of resolution for Mundra power plant in next few weeks
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata Power hopeful of resolution for Mundra power plant in next few weeks
Mar 11, 2020 6:14 AM

Tata Power stock has been under pressure on the back of Mundra power plant issue. The management earlier had indicated that if they do not find a resolution by March 10, then they would have to shut down the power plant.

However, on Wednesday, the management suggested that normal operations would continue at Mundra power plant till March 20, this after a meeting was held with the Union Power Secretary on March 9.

The meeting was attended by the 5 procurers of the plant. There were positive comments discussed and hence the management is hopeful of a resolution in the next few weeks, reports CNBC-TV18.

The Union Power Secretary is expected to hold another meeting in the coming days where a positive resolution is expected.

Mundra power plant is very important for Tata Power. It has accumulated losses of around Rs 11,000 crore and so, in the near term it would be positive if the plant was shut down because the losses would go away. However, the entire loss of the company would continue and would have to be written down and that is a worrying point for the street.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Regenxbio Says Longer-Term Trial Data Show RGX-121's Ability to Improve Outcomes for Hunter Syndrome Patients
Regenxbio Says Longer-Term Trial Data Show RGX-121's Ability to Improve Outcomes for Hunter Syndrome Patients
Sep 5, 2025
07:58 AM EDT, 09/05/2025 (MT Newswires) -- Regenxbio ( RGNX ) said Friday that longer-term data from a phase I/II/III trial of clemidsogene lanparvovec, or RGX-121, further showed the ability of one-time treatment to improve outcomes for patients with Mucopolysaccharidosis Type II, or Hunter syndrome. The company said it has submitted the 12-month data to the US Food and Drug...
Saia LTL Shipments Decline in July, August
Saia LTL Shipments Decline in July, August
Sep 5, 2025
08:04 AM EDT, 09/05/2025 (MT Newswires) -- Saia ( SAIA ) said Friday that less-than-truckload, or LTL, shipments per workday dropped 1.2% in July and 2.2% in August, compared with the same periods a year earlier. The company's LTL tonnage per workday grew 0.9% in July but declined 2.2% in August. Meanwhile, its LTL weight per shipment in July and...
Braze Lifts Outlook As CEO Says AI Will Power Next Growth Wave
Braze Lifts Outlook As CEO Says AI Will Power Next Growth Wave
Sep 5, 2025
Braze Inc. ( BRZE ) shares continued to surge in premarket trading on Friday after the company reported fiscal second-quarter 2026 revenue of $180.1 million, up 23.8% from $145.5 million a year earlier, beating the $170.1 million analyst estimate. Subscription revenue reached $171.8 million, while professional services and other revenue totaled $8.3 million. The remaining performance obligations were $862.2 million,...
Update: Braze Shares Rise After Fiscal Q2 Adjusted Earnings, Revenue Beat Consensus
Update: Braze Shares Rise After Fiscal Q2 Adjusted Earnings, Revenue Beat Consensus
Sep 5, 2025
08:00 AM EDT, 09/05/2025 (MT Newswires) -- (Updates with latest stock movement in headline and first paragraph.) Braze (BRZE) shares were up more than 21% in recent premarket activity Friday after the company reported fiscal Q2 adjusted earnings and revenue that surpassed analysts' consensus. The company reported fiscal Q2 adjusted earnings late Thursday of $0.15 per diluted share, up from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved